The Efficacy and Mechanism of DBS in VIC and NAcc for Refractory OCD

Last updated: January 11, 2020
Sponsor: Ruijin Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Panic Disorders

Anxiety Disorders

Treatment

N/A

Clinical Study ID

NCT04228744
2019 NAc VIC DBS OCD
  • Ages 18-65
  • All Genders

Study Summary

This study will evaluate the efficacy and explore the mechanism of deep brain stimulation (DBS) in the ventral internal capsule (VIC) and nucleus accumbens (NAc) for refractory obsessive-compulsive disorder (OCD).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Diagnosis of OCD with duration of at least 5 years;

  2. Severity rated as severe to extreme illness;

  3. Failed adequate trial of at least three specific serotonin reuptake inhibitor (SSRI)antidepressants;

  4. Failed augmentation with antipsychotic;

  5. Completed or failed to complete adequate trial of cognitive behavioural therapy forOCD;

  6. Stable medication regimen for one month before surgery;

  7. Signed informed consent;

Exclusion

Exclusion Criteria:

  1. Hoarding as a primary symptom;

  2. No other serious psychiatric disorder such as psychotic disorder;

  3. Drug or substance use disorder within 6 months except nicotine;

  4. Major Neurological/Medical condition;

  5. High suicide risk;

  6. Pregnancy or lactation;

  7. Contraindications to stereotactic surgery;

  8. Contraindications to MRI;

Study Design

Total Participants: 20
Study Start date:
January 10, 2020
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • Ruijin Hospital

    Shanghai,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.